CD14 and type 2 diabetes mellitus: The undifferentiated CD14+CD16− M0-like monocytes, show a moderate reduction in T2D blood compared to healthy subjects (257 ± 9 and 294 ± 20/μl respectively), while the M2-like CD14+CD16+ cells show no difference between the groups (Fig. 4b, c).